Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter. With a world-class, FDA-accredited manufacturing facility in Sydney and operations in the United States, Canada, Middle East and Asia-Pacific, Parnell is committed to the continued development of innovative products at the highest standard. Parnell currently markets products for companion, performance and production animals enhanced with proprietary software platforms designed to improve compliance and clinical outcomes. Parnell is poised to bring several new products to market over the next five years, addressing up to 12 indications and needs, with a particular focus on the companion animal sector. At Parnell, we believe the combination of our current product portfolio, pipeline of product candidates and business solutions position us to become a leading innovator in animal health. Our value-added approach establishes us as a business partner with our customers, not a commodity provider. That is the Parnell difference.